Faisal Ghiath Sukhtian, Director at Outlook Therapeutics, holds 220.97K shares in Outlook Therapeutics (Ticker: OTLK), holds ― shares in Oncobiologics Inc (Ticker: ONSIU). Most recently, Faisal Ghiath Sukhtian Bought ― shares of Outlook Therapeutics on Jul 29, 2026 for an estimated value of $99.21K.
What is the percentage of profitable transactions made by Faisal Ghiath Sukhtian?
The percentage of profitable transactions made by Faisal Ghiath Sukhtian is 50%.
What is the average return per transaction made by Faisal Ghiath Sukhtian?
The average return per transaction made by Faisal Ghiath Sukhtian is 21.10%.
What stocks does Faisal Ghiath Sukhtian hold?
Faisal Ghiath Sukhtian holds: OTLK, ONSIU stocks.
What was Faisal Ghiath Sukhtian’s latest transaction?
Faisal Ghiath Sukhtian latest transaction was an Informative Buy of $99.21K.
What was Faisal Ghiath Sukhtian's most profitable transaction?
Faisal Ghiath Sukhtian’s most profitable transaction was an Informative Buy of OTLK stock on September 17, 2020. The return on the trade was 265.10%.
What is Faisal Ghiath Sukhtian's role in Outlook Therapeutics?
Faisal Ghiath Sukhtian's role in Outlook Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.